Tag: API

Medication risk analysis company MDI Health raises $20M

Medication risk analysis company MDI Health raises $20M

MobiHealthNews

Healthcare analytics company MDI Health scored $20 million in Series A funding, bringing the company’s total funding to $26 million.Intel Capital led the round, with participation from Maverick Ventures Israel, alongside existing investors Fresh.Fund, Arc Impact, Hanaco Ventures, Jumpspeed Ventures, former Optum senior vice president Richard Montwill, Welltech Ventures and Basad Ventures.
Yoni Greifman, Intel Capital’s investment director, will join MDI’s board of directors.
WHAT IT DOES
Israel-based MDI offers an AI-enabled tool that provides medication risk analysis based on a patient’s medical records with the aim of preventing adverse drug reactions.
The funds will help the company scale its U.S. and Israeli research and…

Continue Reading
Primary care tech company Elation Health acquires billing platform Lightning MD

Primary care tech company Elation Health acquires billing platform Lightning MD

MobiHealthNews

Elation Health, which offers tools for telehealth, patient engagement and an EHR geared toward primary care providers, announced on Thursday that it had acquired billing and practice-management company Lightning MD.Elation said it would combine the billing and revenue cycle software with its tools to offer an all-in-one product in beta starting this summer. Practices who use other management and billing software through Elation’s API will still have that option. 
Founded in 2017, Lightning MD partnered to integrate with Elation’s services last year. 
“Healthcare technology is rapidly evolving, particularly in the primary care sector where we have the greatest opportunity to improve patient outcomes and…

Continue Reading
TBD Health Raises $4.4M Seed Round to Expand its Hybrid Sexual Healthcare Offerings Nationally

TBD Health Raises $4.4M Seed Round to Expand its Hybrid Sexual Healthcare Offerings Nationally

Healthcare IT Today

As Reproductive Rights are Defunded and Debated Nationally, TBD Health Aims to Democratize Access to Inclusive Sexual Care
TBD Health, a sexual healthcare provider revolutionizing the medical landscape through unparalleled digital and in-person clinical care, today announced a $4.4 million seed round led by Tusk Venture Partners, with participation from Springdale Ventures, Human Ventures, Expansion VC, Starbloom Capital, Hyphen Capital, and The Community Fund along with several strategic angels. With this new financing, TBD Health is expanding to all 50 states, democratizing access to its sexual healthcare offerings, consisting of at-home STD testing and emergency contraception available via telehealth or in-person in its Las…

Continue Reading
Blood Biotech Grifols Cuts Deep in the U.S. to Find €400M in Savings

Blood Biotech Grifols Cuts Deep in the U.S. to Find €400M in Savings

MedCity News

Grifols, a company that turns blood plasma into therapies for immunological disorders and other conditions, is laying off about 2,000 U.S. workers as part of a corporate restructuring projected to yield up to €400 million in annual cost savings, the biotech announced Wednesday.
The layoffs represent about 8% of the Barcelona-based company’s global workforce, but they will happen mainly in its U.S. plasma operations. That’s notable because as a company that relies on plasma, the U.S. is vital to its business. The starting point for Grifols’s therapies is blood plasma. Key to its drug-making process is fractionation, in which the protein components…

Continue Reading
HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

MedCity News

The U.S. Department of Health & Human Services (HHS) unveiled three new models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models include access to $2 generic drugs.
The news is in response to President Joe Biden’s executive order issued in October, which directed HHS to find ways to lower prescription drug costs and improve access to drug therapies for those enrolled in Medicare and Medicaid health plans. The models are meant to build on the Inflation Reduction Act of 2022, which includes allowing Medicare to negotiate lower prescription drug prices for…

Continue Reading
MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MedCity News

A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its first human test this summer—about one year after Replay emerged from stealth. It owes this rapid progress to a cell therapy pioneer’s technology that has already been de-risked by a big pharmaceutical company.
Replay calls itself a genome writing company. With operations split between San Diego and London, the private equity-backed business launched last July with $55 million and a suite of technologies…

Continue Reading
Self-Assembling Peptides as a Bioink

Self-Assembling Peptides as a Bioink

Medgadget

Researchers at Rice University have developed a bioprinting method that uses self-assembling peptides as a bioink. The technique involves using “multidomain peptides” that are hydrophobic at one end and hydrophilic at the other. When the peptides encounter water, they flip over each other to create hydrophobic sandwich structures that stack together to form fibers, creating the base structure of the printed hydrogel. This self-assembly helps the printed material to rapidly form a structure, and it will also reform after deformation. What makes the peptides highly suited for use in implanted constructs is their track record of safe use in the […]…

Continue Reading
Singapore's iHiS taps Google Cloud, Accenture to drive healthcare innovation

Singapore’s iHiS taps Google Cloud, Accenture to drive healthcare innovation

Healthcare IT news

Integrated Health Information Systems, Singapore’s national healthcare technology agency, has collaborated with Google Cloud and Accenture to promote the development of data-driven applications to “deliver more high-quality and digital-first healthcare experiences.”Accenture is helping deploy Apigee, Google Cloud’s API management platform, which will provide third-party developers access to data and services across iHiS’s managed systems to create new applications and capabilities. 
The resulting flexible API-based architecture from this collaboration will serve as a “connective tissue across data sources and applications,” as per iHiS assistant chief executive Alan Goh. 
Google Cloud has also built security features into the Apigee platform to provide iHiS full visibility over…

Continue Reading
Electrochemical Sensor for Detailed SARS-CoV-2 Immunity Data

Electrochemical Sensor for Detailed SARS-CoV-2 Immunity Data

Medgadget

Researchers at the Harvard Wyss Institute have developed an electrochemical device, called the eRapid sensor, that can assist clinicians in quickly characterizing someone’s COVID-19 infection, including identifying the infecting viral variant and the nature of someone’s immunity to the virus in terms of whether it is vaccine-mediated or natural immunity. Monitoring these characteristics could help to personalize treatment for individuals and also provide data for drug development and inform government decisions on the best way to manage COVID-19 in the community. When antibodies from a blood sample bind within the device, it precipitates a biochemical cascade that affects the electrical […]…

Continue Reading
95% of Certified Health IT Developers Met ONC Cures Act Deadline

95% of Certified Health IT Developers Met ONC Cures Act Deadline

DistilINFO Hospital IT

– More than 95 percent of certified health IT developers met the Cures Act Final Rule compliance deadline to provide customers with new technology, according to an ONC HealthITBuzz blog post. The Cures Act Final Rule mandated many changes to the Certification Program, including four updates set to have long-lasting interoperability impacts on patients, clinicians, and developers. ONC Certified Health IT developers must: Advance interoperability for patients and providers through the use of FHIR-based application programming interfaces (APIs);Enable patients, providers, and other stakeholders to have access to consistent data elements represented in at least version one of the United States Core…

Continue Reading